PET-based risk stratification for adverse events under [225Ac]Ac-PSMA radioligand therapy.
Saved in:
| Title: | PET-based risk stratification for adverse events under [225Ac]Ac-PSMA radioligand therapy. |
|---|---|
| Authors: | Widjaja L; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany. Liam.Widjaja@med.uni-muenchen.de.; Bavarian Cancer Research Center (BZKF), partner site Munich, Munich, Germany. Liam.Widjaja@med.uni-muenchen.de., Siegmund SC; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.; Bavarian Cancer Research Center (BZKF), partner site Munich, Munich, Germany., Gildehaus FJ; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Schmidt-Hegemann NS; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany., Pomper MG; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Rowe SP; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Bundschuh RA; Department of Nuclear Medicine, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; Institute of Radiopharmaceutical Cancer Research, Helmholtz Zentrum Dresden- Rossendorf (HZDR), Rossendorf, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; Faculty of Medicine, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Wenter V; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Sheikh GT; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Klimek K; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Stief CG; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany., Zacherl MJ; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Werner RA; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and LMU University Hospital Munich, Munich, Germany., Casuscelli J; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany. |
| Source: | European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Jun; Vol. 53 (7), pp. 4360-4373. Date of Electronic Publication: 2026 Feb 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
